Aimmune's peanut allergy drug meets main goal of key study

Aimmune's peanut allergy drug meets main goal of key study  Reuters Aimmune's peanut allergy drug succeeds in late stage clinical trial  Financial Times Peanut allergy therapy scores trial win, putting it in line to possibly become first protective treatment  STATFull coverage

Read More ...
Aimmune's peanut allergy drug meets main goal of key study published February 20, 2018 at 07:33PM. Original Source Link : https://www.reuters.com/article/us-aimmune-study/aimmunes-peanut-allergy-drug-meets-main-goal-of-key-study-idUSKCN1G41H6

loading...